Brigitte Neuber

1.4k total citations
42 papers, 698 citations indexed

About

Brigitte Neuber is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Brigitte Neuber has authored 42 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 20 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in Brigitte Neuber's work include CAR-T cell therapy research (32 papers), Virus-based gene therapy research (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (12 papers). Brigitte Neuber is often cited by papers focused on CAR-T cell therapy research (32 papers), Virus-based gene therapy research (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (12 papers). Brigitte Neuber collaborates with scholars based in Germany, China and Japan. Brigitte Neuber's co-authors include Carsten Müller‐Tidow, Michael Schmitt, Maria‐Luisa Schubert, Lei Wang, Peter Dreger, Anita Schmitt, Angela Hückelhoven‐Krauss, Leopold Sellner, Susanne Hofmann and Ulrike Gern and has published in prestigious journals such as Blood, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Brigitte Neuber

41 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Neuber Germany 16 529 260 229 169 157 42 698
Sanfang Tu China 16 582 1.1× 297 1.1× 201 0.9× 154 0.9× 166 1.1× 52 858
Tatsunori Goto Japan 14 435 0.8× 216 0.8× 240 1.0× 146 0.9× 152 1.0× 48 723
Susanne Hofmann Germany 14 462 0.9× 303 1.2× 284 1.2× 125 0.7× 287 1.8× 36 757
Sunil S. Raikar United States 13 405 0.8× 205 0.8× 252 1.1× 111 0.7× 108 0.7× 37 639
Katherine D. Cummins United States 8 408 0.8× 281 1.1× 123 0.5× 147 0.9× 175 1.1× 18 595
Namiko Okuyama Japan 6 747 1.4× 285 1.1× 467 2.0× 163 1.0× 215 1.4× 9 945
Reona Sakemura United States 13 717 1.4× 249 1.0× 261 1.1× 227 1.3× 70 0.4× 54 879
Frederic B. Thalheimer Germany 13 494 0.9× 377 1.4× 195 0.9× 240 1.4× 61 0.4× 24 744
Ruihao Huang China 10 356 0.7× 171 0.7× 199 0.9× 104 0.6× 88 0.6× 29 546
Margot J. Pont United States 13 600 1.1× 326 1.3× 235 1.0× 118 0.7× 251 1.6× 27 798

Countries citing papers authored by Brigitte Neuber

Since Specialization
Citations

This map shows the geographic impact of Brigitte Neuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Neuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Neuber more than expected).

Fields of papers citing papers by Brigitte Neuber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Neuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Neuber. The network helps show where Brigitte Neuber may publish in the future.

Co-authorship network of co-authors of Brigitte Neuber

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Neuber. A scholar is included among the top collaborators of Brigitte Neuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Neuber. Brigitte Neuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schairer, Rebekka, Hildegard Keppeler, Hannes Schmid, et al.. (2024). PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. Journal for ImmunoTherapy of Cancer. 12(1). e007829–e007829. 7 indexed citations
2.
Schubert, Maria‐Luisa, Peter Dreger, Anita Schmitt, et al.. (2024). Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study. Leukemia. 38(11). 2419–2428. 18 indexed citations
3.
Wang, Lei, Brigitte Neuber, Angela Hückelhoven‐Krauss, et al.. (2024). Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy. Blood Advances. 8(11). 2675–2690. 3 indexed citations
4.
Chen, Qian, Yao Hao, Brigitte Neuber, et al.. (2024). Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia. Journal of Hematology & Oncology. 17(1). 85–85. 9 indexed citations
5.
Liu, Yibin, Brigitte Neuber, Lei Wang, et al.. (2023). Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma. International Journal of Molecular Sciences. 24(3). 1943–1943. 5 indexed citations
6.
Gong, Wenjie, Lei Wang, Maria‐Luisa Schubert, et al.. (2022). HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma. Biomedicines. 10(2). 373–373. 4 indexed citations
7.
Bunse, Lukas, Claudia Sommerer, Chin Leng Tan, et al.. (2022). Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV. International Journal of Molecular Sciences. 23(3). 1029–1029. 2 indexed citations
8.
Schubert, Maria‐Luisa, Carolina Berger, Alexander Kunz, et al.. (2022). Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients. International Journal of Oncology. 60(5). 9 indexed citations
9.
Gong, Wenjie, Lei Wang, Sophia Stock, et al.. (2021). Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells. Cells. 10(1). 152–152. 4 indexed citations
10.
11.
Schubert, Maria‐Luisa, Alexander Kunz, Anita Schmitt, et al.. (2020). Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR. Cancers. 12(10). 2820–2820. 14 indexed citations
12.
Yoo, Keun-Young, Sophia Stock, Lei Wang, et al.. (2020). Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients. International Journal of Cancer. 148(2). 419–428. 52 indexed citations
13.
Kunz, Alexander, Ulrike Gern, Anita Schmitt, et al.. (2020). Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients. Molecular Therapy — Methods & Clinical Development. 17. 448–454. 28 indexed citations
14.
Yang, Mingya, Lei Wang, Ming Ni, et al.. (2020). Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells. Frontiers in Immunology. 11. 608167–608167. 32 indexed citations
15.
Yoo, Keun-Young, Yibin Liu, Lei Wang, et al.. (2019). Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. International Journal of Molecular Sciences. 20(10). 2469–2469. 15 indexed citations
16.
Wang, Lei, Wenjie Gong, Sanmei Wang, et al.. (2019). Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells. Cytotherapy. 21(5). 566–578. 17 indexed citations
17.
18.
Stock, Sophia, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.. (2018). Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells. Human Gene Therapy. 29(10). 1167–1182. 21 indexed citations
19.
Engelhardt, Mélanie, Hakim Echchannaoui, Marc S. Raab, et al.. (2018). IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells. Cancer Immunology Immunotherapy. 67(11). 1695–1707. 15 indexed citations
20.
Neuber, Brigitte, Ute Hegenbart, Dirk Hose, et al.. (2011). Lenalidomide Enhances Antigen-Specific Activity and Decreases CD45RA Expression of T Cells from Patients with Multiple Myeloma. The Journal of Immunology. 187(2). 1047–1056. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanfang Tu Breakdown of academic impact, for papers by Tatsunori Goto Breakdown of academic impact, for papers by Susanne Hofmann Breakdown of academic impact, for papers by Sunil S. Raikar Breakdown of academic impact, for papers by Katherine D. Cummins Breakdown of academic impact, for papers by Namiko Okuyama Breakdown of academic impact, for papers by Reona Sakemura Breakdown of academic impact, for papers by Frederic B. Thalheimer Breakdown of academic impact, for papers by Ruihao Huang Breakdown of academic impact, for papers by Margot J. Pont
Rankless by CCL
2026